LIMITED-STAGE SMALL CELL LUNG CANCER
Clinical trials for LIMITED-STAGE SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LIMITED-STAGE SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LIMITED-STAGE SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for lung cancer patients: maintenance drug trial launches
Disease control Recruiting nowThis study tests a drug called tarlatamab as a maintenance treatment for people with limited-stage small cell lung cancer who cannot receive standard chemo-radiotherapy together. About 37 participants will receive tarlatamab infusions after initial treatment to see if it delays c…
Matched conditions: LIMITED-STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated May 26, 2026 04:49 UTC
-
New drug combo aims to extend life in lung cancer patients
Disease control Recruiting nowThis study tests whether a new drug combination (BMS-986489) works better than the current standard drug (durvalumab) as follow-up treatment after chemoradiation for limited-stage small cell lung cancer. About 250 adults will take part. The goal is to see if the new combo helps p…
Matched conditions: LIMITED-STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: SCRI Development Innovations, LLC • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Gut health meets cancer care: new combo trial for lung cancer
Disease control Recruiting nowThis study tests whether adding probiotics to standard chemo-radiation and an immunotherapy drug (adebrelimab) can improve outcomes for people with limited-stage small cell lung cancer. About 60 adults aged 18-80 will take part. The goal is to see if this combination helps keep c…
Matched conditions: LIMITED-STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New hope for lung cancer: drug after radiation may keep disease at bay
Disease control Recruiting nowThis study looks at whether the drug durvalumab, given after standard chemoradiation, can help people with limited-stage small-cell lung cancer live longer without their cancer getting worse. About 200 adults in China will take part. The goal is to see how well the drug works in …
Matched conditions: LIMITED-STAGE SMALL CELL LUNG CANCER
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New combo therapy aims to fight tough lung cancer
Disease control Recruiting nowThis study tests a combination of two drugs, monalizumab and durvalumab, along with standard chemotherapy, for people with small cell lung cancer. The goal is to see if this mix helps keep the cancer from growing longer. About 84 adults with either extensive-stage or limited-stag…
Matched conditions: LIMITED-STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Hirva Mamdani • Aim: Disease control
Last updated May 20, 2026 11:55 UTC